Organism name | Athyrium mesosorum |
---|---|
Genus | Athyrium |
Family | Woodsiaceae / Dryopteridaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Athyrium |
---|---|
Linked NCBI taxonomy ID | 32109 |
Linked level | genus |
Family in NCBI taxonomy | Athyriaceae |
---|---|
ID | 1203520 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Euphyllophyta |
---|---|
ID | 78536 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002942
![]() |
Athyriol
|
No. 3 | No. 15 |
![]() |
||||
C00002956
![]() |
Isoathyriol
|
No. 3 | No. 15 |
![]() |
||||
C00002962
![]() |
Aphloiol
/ Mangiferin / 2-beta-D-Glucopyranosyl-1,3,6,7-tetrahydroxy xanthone |
CHEMBL1329826
|
C013592
|
27 / 17 / 17 | 39 / 41 | No. 22 | No. 15 |
![]() |
C00002968
![]() |
Norathyriol
/ 1,3,6,7-Tetrahydroxyxanthoene |
CHEMBL187265
|
C069053
|
9 / 10 / 7 | 4 / 0 | No. 71 | No. 15 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002962 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002962 | 0 / 0 |
P39900 | Macrophage metalloelastase | M10A | C00002968 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002968 | 2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002962 | 0 / 0 |
Q9Y5X4 | Photoreceptor-specific nuclear receptor | NR2E3 | C00002962 | 2 / 2 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002968 | 1 / 1 |
P49327 | Fatty acid synthase | Transferase | C00002968 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002962 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002962 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002962 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00002968 | 0 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002962 | 1 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00002962 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00002962 | 3 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002962 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002962 | 0 / 0 |
P45452 | Collagenase 3 | M10A | C00002968 | 1 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00002962 | 0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00002968 | 1 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002962 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002962 | 2 / 2 |
P12821 | Angiotensin-converting enzyme | M2 | C00002968 | 4 / 2 |
P55210 | Caspase-7 | C14 | C00002962 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002962 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002962 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002962 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002968 | 1 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002962 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002962 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002962 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002962 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002962 | 1 / 4 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002962 | 5 / 3 |
Q9Y618 | Nuclear receptor corepressor 2 | Unclassified protein | C00002962 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002962 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002962
C00002968
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00002962
C00002968
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002962
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002962
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002962
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002962
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002962
|
891 | CCNB1, CCNB | cyclin B1 |
C00002962
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00002962
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002962
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002962
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002962
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002962
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002962
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00002962
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00002962
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002962
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002962
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002962
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002962
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002962
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002962
|
4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00002962
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002962
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002962
|
4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00002962
|
4803 | NGF, Beta-NGF, HSAN5, NGFB | nerve growth factor (beta polypeptide) |
C00002962
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00002962
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002962
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002962
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002962
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00002962
|
7015 | TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | telomerase reverse transcriptase (EC:2.7.7.49) |
C00002962
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002962
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002962
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002962
|
7364 | UGT2B7, UDPGT_2B9, UDPGT2B7, UDPGTH2, UGT2B9 | UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) |
C00002962
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002962
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002962
|
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00002968
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002968
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#268100 | Enhanced s-cone syndrome; escs |
Q9Y5X4
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#601665 | Obesity |
P37231
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#611131 | Retinitis pigmentosa 37; rp37 |
Q9Y5X4
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#601367 | Stroke, ischemic |
P12821
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00028 | Choriocarcinoma |
P03956
(related)
P08253 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
H00527 | Retinitis pigmentosa (RP) |
Q9Y5X4
(related)
|
H00805 | Vitreoretinal degeneration |
Q9Y5X4
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D016301 | Alveolar Bone Loss |
C00002962
|
D000707 | Anaphylaxis |
C00002962
|
D050197 | Atherosclerosis |
C00002962
|
D001847 | Bone Diseases |
C00002962
|
D001862 | Bone Resorption |
C00002962
|
D003248 | Constipation |
C00002962
|
D003457 | Cryptosporidiosis |
C00002962
|
D003921 | Diabetes Mellitus, Experimental |
C00002962
|
D003924 | Diabetes Mellitus, Type 2 |
C00002962
|
D003928 | Diabetic Nephropathies |
C00002962
|
D056486 | Drug-Induced Liver Injury |
C00002962
|
D005234 | Fatty Liver |
C00002962
|
D006331 | Heart Diseases |
C00002962
|
D006561 | Herpes Simplex |
C00002962
|
D015658 | HIV Infections |
C00002962
|
D006946 | Hyperinsulinism |
C00002962
|
D006949 | Hyperlipidemias |
C00002962
|
D006967 | Hypersensitivity |
C00002962
|
D033461 | Hyperuricemia |
C00002962
|
D007154 | Immune System Diseases |
C00002962
|
D007249 | Inflammation |
C00002962
|
D007333 | Insulin Resistance |
C00002962
|
D007511 | Ischemia |
C00002962
|
D007674 | Kidney Diseases |
C00002962
|
D007859 | Learning Disorders |
C00002962
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002962
|
D015470 | Leukemia, Myeloid, Acute |
C00002962
|
D008175 | Lung Neoplasms |
C00002962
|
D008569 | Memory Disorders |
C00002962
|
D008630 | Mercury Poisoning |
C00002962
|
D009203 | Myocardial Infarction |
C00002962
|
D009336 | Necrosis |
C00002962
|
D009410 | Nerve Degeneration |
C00002962
|
D009437 | Neuralgia |
C00002962
|
D010300 | Parkinson Disease |
C00002962
|
D010518 | Periodontitis |
C00002962
|
D011470 | Prostatic Hyperplasia |
C00002962
|
D011833 | Radiation Injuries, Experimental |
C00002962
|
D012772 | Shock, Septic |
C00002962
|
D013276 | Stomach Ulcer |
C00002962
|
D014235 | Trichinellosis |
C00002962
|